Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Matteo Allegretti, Alessandra Fabi, Simonetta Buglioni, Aline Martayan, Laura Conti, Edoardo Pescarmona, Gennaro Ciliberto, Patrizio Giacomini

Journal title: Journal of Experimental & Clinical Cancer Research

Journal number: 37/1

Journal publisher: BMC

Published year: 2018

DOI identifier: 10.1186/s13046-018-0702-x

ISSN: 1756-9966